224 related articles for article (PubMed ID: 32822716)
1. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications.
Dróżdż M; Makuch S; Cieniuch G; Woźniak M; Ziółkowski P
Life Sci; 2020 Nov; 261():118296. PubMed ID: 32822716
[TBL] [Abstract][Full Text] [Related]
2. Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.
Yu B; Yang M; Shi L; Yao Y; Jiang Q; Li X; Tang LH; Zheng BJ; Yuen KY; Smith DK; Song E; Huang JD
Sci Rep; 2012; 2():436. PubMed ID: 22666539
[TBL] [Abstract][Full Text] [Related]
3. Salmonella-allies in the fight against cancer.
Leschner S; Weiss S
J Mol Med (Berl); 2010 Aug; 88(8):763-73. PubMed ID: 20526574
[TBL] [Abstract][Full Text] [Related]
4. Efficient tumor targeting by anaerobic butyrate-producing bacteria.
Tirandaz H; Mohammadi E
Med Hypotheses; 2013 May; 80(5):675-8. PubMed ID: 23410499
[TBL] [Abstract][Full Text] [Related]
5. [Advances in tumor-therapy using genetically modified Salmonella].
Liang K; Zhao X; Yi J; Liu Q; Liu Q; Kong Q
Sheng Wu Gong Cheng Xue Bao; 2016 May; 32(5):565-576. PubMed ID: 29019195
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Biology Medicine and Bacteria-Based Cancer Therapeutics.
Lee J; Keates AC; Li CJ
Methods Mol Biol; 2021; 2323():267-280. PubMed ID: 34086287
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review).
Liu S; Xu X; Zeng X; Li L; Chen Q; Li J
Oncol Lett; 2014 Dec; 8(6):2359-2366. PubMed ID: 25364397
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.
Liang K; Liu Q; Li P; Luo H; Wang H; Kong Q
Cancer Lett; 2019 Apr; 448():168-181. PubMed ID: 30753837
[TBL] [Abstract][Full Text] [Related]
9. Targeting solid tumors with non-pathogenic obligate anaerobic bacteria.
Taniguchi S; Fujimori M; Sasaki T; Tsutsui H; Shimatani Y; Seki K; Amano J
Cancer Sci; 2010 Sep; 101(9):1925-32. PubMed ID: 20579076
[TBL] [Abstract][Full Text] [Related]
10. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.
Wei MQ; Ellem KA; Dunn P; West MJ; Bai CX; Vogelstein B
Eur J Cancer; 2007 Feb; 43(3):490-6. PubMed ID: 17113280
[TBL] [Abstract][Full Text] [Related]
11. Bacteria and bacterial toxins as therapeutic agents for solid tumors.
Michl P; Gress TM
Curr Cancer Drug Targets; 2004 Dec; 4(8):689-702. PubMed ID: 15578923
[TBL] [Abstract][Full Text] [Related]
12. Methods for the development of tumor-targeting bacteria.
Hoffman RM; Zhao M
Expert Opin Drug Discov; 2014 Jul; 9(7):741-50. PubMed ID: 24949888
[TBL] [Abstract][Full Text] [Related]
13. Role of encapsulated anaerobic bacteria in synergistic infections.
Brook I
Crit Rev Microbiol; 1987; 14(3):171-93. PubMed ID: 3556018
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific gene delivery using genetically engineered bacteria.
Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
[TBL] [Abstract][Full Text] [Related]
15. Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery.
Lin D; Feng X; Mai B; Li X; Wang F; Liu J; Liu X; Zhang K; Wang X
Biomaterials; 2021 Oct; 277():121124. PubMed ID: 34534860
[TBL] [Abstract][Full Text] [Related]
16. Use of Bacteria in Cancer Therapy.
Sarotra P; Medhi B
Recent Results Cancer Res; 2016; 209():111-121. PubMed ID: 28101691
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and aerobic and anaerobic microbiological characteristics of cellulitis.
Brook I; Frazier EH
Arch Surg; 1995 Jul; 130(7):786-92. PubMed ID: 7611872
[TBL] [Abstract][Full Text] [Related]
18. New technologies in developing recombinant-attenuated bacteria for cancer therapy.
Liang K; Liu Q; Kong Q
Biotechnol Bioeng; 2021 Feb; 118(2):513-530. PubMed ID: 33038015
[TBL] [Abstract][Full Text] [Related]
19. Potential and limitations of bacterial-mediated cancer therapy.
Mengesha A; Dubois L; Chiu RK; Paesmans K; Wouters BG; Lambin P; Theys J
Front Biosci; 2007 May; 12():3880-91. PubMed ID: 17485344
[TBL] [Abstract][Full Text] [Related]
20. Distribution of metronidazole susceptibility factors in obligate anaerobes.
Narikawa S
J Antimicrob Chemother; 1986 Nov; 18(5):565-74. PubMed ID: 3804881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
